Saturday, January 26, 2019

Ezetimibe Oral : Uses, Side Effects, Interactions




Ezetimibe

Uses

Ezetimibe is used with the following cholesterol / low fat diet and helps lower blood cholesterol. Ezetimibe can be used alone or with other medications (such as “statins” or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol can help prevent stroke and heart attack.

How to use Ezetimibe

If you start taking your ezetimibe and you receive a refill every time, then read the information leaflet available from your pharmacist. If you have any questions, ask your doctor or pharmacist.
Take this medicine guided by your doctor, usually once daily or without food.
Dosage is based on your medical condition and treatment response.
If bile acids are taking sequencer (such as cholestyramine, colestipol), then take asymmetry at least 2 hours or 4 hours after taking bile acid sequencer. These products can bind your body completely with the absorption of ezetimibe.
Take Ezetimibe regularly to get the most benefit of this. To help you remember, take it every day at the same time.
It is important to continue taking this medicine even if you feel OK. Most people with high cholesterol do not feel sick. You can take up to 2 weeks before receiving the full benefit of this drug.

Side Effects

Remember that your doctor has prescribed this drug because he or she has decided that your benefit is higher than the risk of side effects. Many people using this drug do not have serious side effects.
Ezetimibe can increase the risk of liver damage (when taken with a “statin”) or muscle damage occurs when a fibrate or “statin” is taken along. Tell your doctor immediately if you have any of the following symptoms: symptoms of liver problems (such as severe stomach / stomach ache, persistent nausea / vomiting, blinking of eyes / skin, urination is yellow), muscles Pain in / softness (weakness) fever or abnormal fatigue). Read More


from Dr. Linex http://bit.ly/2UjmYT8
via IFTTT

0 comments:

Post a Comment